11/24/2010

Congress needs to craft clear, comprehensive policy on research that uses stem cells derived from human embryos to end legal ambiguity surrounding such research, said John Gearhart, a stem cell pioneer and head of the University of Pennsylvania's Institute for Regenerative Medicine. An appeals court will conduct a hearing in December to discuss the legality of providing federal funding for embryonic stem cell research.

Related Summaries